AAAAAA

   
Results: 1-25 | 26-41
Results: 1-25/41
DEVELOPMENT OF A SEEDING TECHNIQUE FOR THE CRYSTALLIZATION OF THE METASTABLE-A MODIFICATION OF ABECARNIL
Authors: BECKMANN W NICKISCH K BUDDE U
Citation: W. Beckmann et al., DEVELOPMENT OF A SEEDING TECHNIQUE FOR THE CRYSTALLIZATION OF THE METASTABLE-A MODIFICATION OF ABECARNIL, Organic process research & development, 2(5), 1998, pp. 298-304
ANTI-FVIII INHIBITOR INCIDENCE IN PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA EXPOSED TO KOGENATE(R) (GIPSI-GERMAN-ITALIAN PUP STUDY ON INHIBITOR)
Authors: GRINGERI A KREUZ W ESCURIOLAETTINGHAUSEN C SANTAGOSTINO E SAGUER IM BADER R BUDDE U MANNUCCI PM
Citation: A. Gringeri et al., ANTI-FVIII INHIBITOR INCIDENCE IN PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA EXPOSED TO KOGENATE(R) (GIPSI-GERMAN-ITALIAN PUP STUDY ON INHIBITOR), Thrombosis research, 91(3), 1998, pp. 13-13
MANAGEMENT OF SEVERE CHRONIC THROMBOCYTOPENIA IN VON-WILLEBRANDS-DISEASE TYPE 2B
Authors: MAUZKORHOLZ C BUDDE U KRUCK H KORHOLZ D GOBEL U
Citation: C. Mauzkorholz et al., MANAGEMENT OF SEVERE CHRONIC THROMBOCYTOPENIA IN VON-WILLEBRANDS-DISEASE TYPE 2B, Archives of Disease in Childhood, 78(3), 1998, pp. 257-260
THROMBOTIC THROMBOCYTOPENIC PURPURA IN THE BRAIN - POSSIBLE PROGNOSTIC IMPACT OF VON-WILLEBRAND-FACTOR PHYSIOLOGY
Authors: VIEREGGE P NEUGEBAUER C REUSCHE E HALLERMANN W BUDDE U HEIDE W OTTO V MENTZEL M HUTTEROTH T
Citation: P. Vieregge et al., THROMBOTIC THROMBOCYTOPENIC PURPURA IN THE BRAIN - POSSIBLE PROGNOSTIC IMPACT OF VON-WILLEBRAND-FACTOR PHYSIOLOGY, European journal of neurology, 4(6), 1997, pp. 601-605
EXCESSIVE PROLONGATION OF THE BLEEDING-TIME BY ASPIRIN IN ESSENTIAL THROMBOCYTHEMIA IS RELATED TO A DECREASE OF LARGE VON-WILLEBRAND-FACTORMULTIMERS IN PLASMA
Authors: VANGENDEREN PJJ VANVLIET HHDM PRINS FJ VANDEMOESDIJK D VANSTRIK R ZIJLSTRA FJ BUDDE U MICHIELS JJ
Citation: Pjj. Vangenderen et al., EXCESSIVE PROLONGATION OF THE BLEEDING-TIME BY ASPIRIN IN ESSENTIAL THROMBOCYTHEMIA IS RELATED TO A DECREASE OF LARGE VON-WILLEBRAND-FACTORMULTIMERS IN PLASMA, Annals of hematology, 75(5-6), 1997, pp. 215-220
RESPONSE TO HIGH-DOSE IGG IN A PATIENT WITH ACQUIRED VON-WILLEBRAND-SYNDROME TYPE-2 CAUSED BY A MONOCLONAL IGG
Authors: BUDDE U DREWKE E BERTHOLD G
Citation: U. Budde et al., RESPONSE TO HIGH-DOSE IGG IN A PATIENT WITH ACQUIRED VON-WILLEBRAND-SYNDROME TYPE-2 CAUSED BY A MONOCLONAL IGG, Thrombosis and haemostasis, 1997, pp. 882-882
DEFECTIVE DIMERIZATION OF VON-WILLEBRAND-FACTOR - A NEW CLASS OF MUTATIONS IN VWD TYPE-2 AND TYPE-3
Authors: SCHNEPPENHEIM R BRASSARD J BUDDE U KREY S SCHWAAB R OLDENBURG J
Citation: R. Schneppenheim et al., DEFECTIVE DIMERIZATION OF VON-WILLEBRAND-FACTOR - A NEW CLASS OF MUTATIONS IN VWD TYPE-2 AND TYPE-3, Thrombosis and haemostasis, 1997, pp. 1585-1585
THE EXCESSIVE PROLONGATION OF THE BLEEDING-TIME BY ASPIRIN IN ESSENTIAL THROMBOCYTHEMIA IS RELATED TO A DECREASE OF LARGE VON-WILLEBRAND-FACTOR MULTIMERS IN PLASMA
Authors: VANGENDEREN PJJ VANVLIET HHDM PRINS FJ VANDEMOESDIJK D VANSTRIK R ZIJLSTRA FJ BUDDE U MICHIELS JJ
Citation: Pjj. Vangenderen et al., THE EXCESSIVE PROLONGATION OF THE BLEEDING-TIME BY ASPIRIN IN ESSENTIAL THROMBOCYTHEMIA IS RELATED TO A DECREASE OF LARGE VON-WILLEBRAND-FACTOR MULTIMERS IN PLASMA, Thrombosis and haemostasis, 1997, pp. 2358-2358
ANTI-FVIII INHIBITOR INCIDENCE IN PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA EXPOSED TO KOGENATE(R) (GIPSI-GERMAN-ITALIAN PUP STUDY ON INHIBITOR)
Authors: GRINGERI A KREUZ W ESCURIOLAETTINGHAUSEN C SIRACUSANO L MARTINEZSAGUER I BADER R BUDDE U MANNUCCI PM
Citation: A. Gringeri et al., ANTI-FVIII INHIBITOR INCIDENCE IN PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA EXPOSED TO KOGENATE(R) (GIPSI-GERMAN-ITALIAN PUP STUDY ON INHIBITOR), Thrombosis and haemostasis, 1997, pp. 2642-2642
NEW FAMILIES WITH VON-WILLEBRAND DISEASE TYPE 2M (VICENZA)
Authors: ZIEGER B BUDDE U JESSAT U ZIMMERMANN R SIMON M KATZEL R SUTOR AH
Citation: B. Zieger et al., NEW FAMILIES WITH VON-WILLEBRAND DISEASE TYPE 2M (VICENZA), Thrombosis research, 87(1), 1997, pp. 57-64
THERAPY FOR SEVERE FACTOR-VII DEFECT IN M EMBERS OF THE JEHOVAH-WITNESS RELIGION
Authors: ZIEGER B VONMONKIEWITSCH T BUDDE U SUTOR AH
Citation: B. Zieger et al., THERAPY FOR SEVERE FACTOR-VII DEFECT IN M EMBERS OF THE JEHOVAH-WITNESS RELIGION, Monatsschrift fur Kinderheilkunde, 145(10), 1997, pp. 1076-1079
DELTA-C IN EXON-18 OF THE VON-WILLEBRAND-FACTOR GENE IS THE MOST COMMON MUTATION IN PATIENTS WITH SEVERE VON-WILLEBRAND-DISEASE TYPE-3 IN POLAND
Authors: GAZDA H BUDDE U KREY S ROKICKAMILEWSKA R SCHNEPPENHEIM R
Citation: H. Gazda et al., DELTA-C IN EXON-18 OF THE VON-WILLEBRAND-FACTOR GENE IS THE MOST COMMON MUTATION IN PATIENTS WITH SEVERE VON-WILLEBRAND-DISEASE TYPE-3 IN POLAND, Blood, 90(10), 1997, pp. 3132-3132
INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATED PATIENTS (PUP) WITH HEMOPHILIA-A TREATED WITH KOGENATE(R) - (GIPSI - GERMAN ITALIAN PUP STUDYON INHIBITOR DEVELOPMENT)
Authors: ETTINGSHAUSEN CE GRINGERI A BUDDE U MANNUCCI PM KREUZ W LUSHER J
Citation: Ce. Ettingshausen et al., INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATED PATIENTS (PUP) WITH HEMOPHILIA-A TREATED WITH KOGENATE(R) - (GIPSI - GERMAN ITALIAN PUP STUDYON INHIBITOR DEVELOPMENT), Blood, 90(10), 1997, pp. 687-687
THE IMMUNE-RESPONSE TO FACTOR-VIII IN HEMOPHILIA-A PATIENTS IS MORE COMPLEX THAN SUGGESTED BY THE BETHESDA ASSAY
Authors: KLINGE J AUERSWALD G BUDDE U KLOSE H KREUZ W LENK H SCANDELLA D
Citation: J. Klinge et al., THE IMMUNE-RESPONSE TO FACTOR-VIII IN HEMOPHILIA-A PATIENTS IS MORE COMPLEX THAN SUGGESTED BY THE BETHESDA ASSAY, Blood, 90(10), 1997, pp. 2056-2056
BLEEDING-TIME AND PLATELET-FUNCTION IN ESSENTIAL THROMBOCYTHEMIA AND OTHER MYELOPROLIFERATIVE SYNDROMES
Authors: FINAZZI G BUDDE U MICHIELS JJ
Citation: G. Finazzi et al., BLEEDING-TIME AND PLATELET-FUNCTION IN ESSENTIAL THROMBOCYTHEMIA AND OTHER MYELOPROLIFERATIVE SYNDROMES, Leukemia & lymphoma, 22, 1996, pp. 71-78
ACQUIRED VON-WILLEBRAND DISEASE IN MYELOPROLIFERATIVE DISORDERS
Authors: VANGENDEREN PJJ LEENKNEGT H MICHIELS JJ BUDDE U
Citation: Pjj. Vangenderen et al., ACQUIRED VON-WILLEBRAND DISEASE IN MYELOPROLIFERATIVE DISORDERS, Leukemia & lymphoma, 22, 1996, pp. 79-82
RESULTS OF A SCREENING FOR VON-WILLEBRAND DISEASE TYPE 2N PATIENTS WITH SUSPECTED HEMOPHILIA-A OR VAN WILLEBRAND DISEASE TYPE-1
Authors: SCHNEPPENHEIM R BUDDE U KREY S DREWKE E BERGMANN F LECHLER E OLDENBURG J SCHWAAB R
Citation: R. Schneppenheim et al., RESULTS OF A SCREENING FOR VON-WILLEBRAND DISEASE TYPE 2N PATIENTS WITH SUSPECTED HEMOPHILIA-A OR VAN WILLEBRAND DISEASE TYPE-1, Thrombosis and haemostasis, 76(4), 1996, pp. 598-602
PREVALENCE OF FACTOR-V LEIDEN IN CHILDREN WITH THROMBOEMBOLISM
Authors: ASCHKA I AUMANN V BERGMANN F BUDDE U EBERL W ECKHOFDONOVAN S KREY S NOWAKGOTTL U SCHOBESS R SUTOR AH WENDISCH J SCHNEPPENHEIM R
Citation: I. Aschka et al., PREVALENCE OF FACTOR-V LEIDEN IN CHILDREN WITH THROMBOEMBOLISM, European journal of pediatrics, 155(12), 1996, pp. 1009-1014
DEFECTIVE DIMERIZATION OF VON-WILLEBRAND-FACTOR SUBUNITS DUE TO A CYS-]ARG MUTATION IN TYPE-IID VON-WILLEBRAND DISEASE
Authors: SCHNEPPENHEIM R BRASSARD J KREY S BUDDE U KUNICKI TJ HOLMBERG L WARE J RUGGERI ZM
Citation: R. Schneppenheim et al., DEFECTIVE DIMERIZATION OF VON-WILLEBRAND-FACTOR SUBUNITS DUE TO A CYS-]ARG MUTATION IN TYPE-IID VON-WILLEBRAND DISEASE, Proceedings of the National Academy of Sciences of the United Statesof America, 93(8), 1996, pp. 3581-3586
THE REDUCTION OF LARGE VON-WILLEBRAND-FACTOR MULTIMERS IN PLASMA IN ESSENTIAL THROMBOCYTHEMIA IS RELATED TO THE PLATELET COUNT
Authors: VANGENDEREN PJJ BUDDE U MICHIELS JJ VANSTRIK R VANVLIET HHDM
Citation: Pjj. Vangenderen et al., THE REDUCTION OF LARGE VON-WILLEBRAND-FACTOR MULTIMERS IN PLASMA IN ESSENTIAL THROMBOCYTHEMIA IS RELATED TO THE PLATELET COUNT, British Journal of Haematology, 93(4), 1996, pp. 962-965
INCIDENCE OF INHIBITORS IN PREVIOUSLY UNTREATED HEMOPHILIA PATIENTS -PRELIMINARY-RESULTS OF A PROSPECTIVE MULTICENTER STUDY OF THE PEDIATRIC WORKING GROUP TO THE GTH MAN-SOCIETY-OF-THROMBOSIS-AND-HEMOSTASIS-RESEARCH)
Authors: KLOSE HJ AUERSWALD G ESCURIOLAETTINGSHAUSEN C KREUZ W LENK H MARTINEZSAGUER I BUDDE U
Citation: Hj. Klose et al., INCIDENCE OF INHIBITORS IN PREVIOUSLY UNTREATED HEMOPHILIA PATIENTS -PRELIMINARY-RESULTS OF A PROSPECTIVE MULTICENTER STUDY OF THE PEDIATRIC WORKING GROUP TO THE GTH MAN-SOCIETY-OF-THROMBOSIS-AND-HEMOSTASIS-RESEARCH), Blood, 88(10), 1996, pp. 3031-3031
IDENTIFICATION OF A SINGLE-BASE DELETION (DELTA-C08565 8566) IN A PATIENT WITH VON-WILLEBRAND DISEASE TYPE 2A (SUBTYPE IIE)/
Authors: SCHNEPPENHEIM R BUDDE U KREY S DREWKE E
Citation: R. Schneppenheim et al., IDENTIFICATION OF A SINGLE-BASE DELETION (DELTA-C08565 8566) IN A PATIENT WITH VON-WILLEBRAND DISEASE TYPE 2A (SUBTYPE IIE)/, Blood, 88(10), 1996, pp. 1294-1294
DRASTIC REDUCTION OF INCUBATION-TIME IN I MMUNOHEMATOLOGICAL STUDIES USING MICROWAVE TECHNIQUES
Authors: BUDDE U GRIMM C SCHMIDT L SCHERLITZKY L POSCHMANN A
Citation: U. Budde et al., DRASTIC REDUCTION OF INCUBATION-TIME IN I MMUNOHEMATOLOGICAL STUDIES USING MICROWAVE TECHNIQUES, Infusionstherapie und Transfusionsmedizin, 22, 1995, pp. 92-94
IDENTIFICATION OF A CANDIDATE MISSENSE MUTATION IN A FAMILY WITH VON-WILLEBRAND-DISEASE TYPE-IIC
Authors: SCHNEPPENHEIM R THOMAS KB KREY S BUDDE U JESSAT U SUTOR AH ZIEGER B
Citation: R. Schneppenheim et al., IDENTIFICATION OF A CANDIDATE MISSENSE MUTATION IN A FAMILY WITH VON-WILLEBRAND-DISEASE TYPE-IIC, Human genetics, 95(6), 1995, pp. 681-686
PREVALENCE OF APC-RESISTANCE IN CHILDREN
Authors: ASCHKA I KREY S BERGMANN F BUDDE U EBERL W ECKHOFDONOVAN S KREUZ W NOWAKGOTTL U PLENDL H SCHOBESS R SCHNEPPENHEIM R
Citation: I. Aschka et al., PREVALENCE OF APC-RESISTANCE IN CHILDREN, Thrombosis and haemostasis, 73(6), 1995, pp. 1121-1121
Risultati: 1-25 | 26-41